trials | Financial Buzz

Biotechnology Healthcare Investing News Market News Medical Use Pharmaceutical Products The Market Buzz

Eli Lilly Beats Earnings Expectations

Rebecca Urena01/29/202101/29/2021

2439

Eli Lilly (NYSE: LLY) surpassed Wall Street Expectations regarding fourth-quarter profit on positive sales of its diabetes and cancer drugs. The American pharmaceutical company reported USD871.2 Million in...

Biotechnology Investing News Market News

Gilead Reports Phase 3 Trial Results in Patients with Coronvirus

Bryan Shin06/01/2020

3995

Gilead Sciences, Inc. (NASDAQ: GILD) reported topline results from its Phase 3 SIMPLE trials in patients with COVID-19 pneumonia. The study evaluated patients on 5-day and 10-day courses of...

Breaking News Cannabis Buzz Market News Medical Use Products Technology The Market Buzz

Breaking News: Cardiol Therapeutics Announces Clinical Steering Committee for Phase 2 International Trial in Acute Myocarditis Using CardiolRx(TM) 100

financial buzz11/19/201912/10/2019

4332

Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF), a leader in the production of pharmaceutical cannabidiol (CBD) products and in the development of innovative cannabidiol medicines for heart disease, is...

Healthcare Investing News Science Technology The Market Buzz

Vital Shares Plunge After Liver Failure Treatment Missed Endpoint

Zehong (Marco) Zhou09/12/201809/12/2018

6653

0

Vital Therapies, Inc. (NASDAQ: VTL) reported its results from its liver failure treatment but failed to meet primary endpoints. Shares plummeted by 89% during Wednesday’s pre-market hours. Vital’s treatment,...

Tag: trials

Eli Lilly Beats Earnings Expectations

Gilead Reports Phase 3 Trial Results in Patients with Coronvirus

Breaking News: Cardiol Therapeutics Announces Clinical Steering Committee for Phase 2 International Trial in Acute Myocarditis Using CardiolRx(TM) 100

Vital Shares Plunge After Liver Failure Treatment Missed Endpoint

ABOUT US

Tweets